Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Although crackles on chest auscultation represent a fundamental component of the diagnostic suspect for fibrotic interstitial lung disease (ILD), their reliability has not been properly studied. We assessed the agreement among respiratory physicians on the presence and changes over time of audible crackles collected in a prospective longitudinal cohort of patients with fibrotic ILD.

Methods: Lung sounds were digitally recorded at baseline and after 12 months at eight anatomical sites. Nine respiratory physicians blindly assessed randomized couples of recordings obtained from the same anatomical site at different timepoints. The physicians indicated the presence of crackles in individual recordings and which recording from each couple eventually had more intense crackles. Fleiss' kappa coefficient was used to measure inter- and intra-rater agreement.

Results: Fifty-two patients, mostly with a diagnosis of IPF (n = 40, 76.9%) were prospectively enrolled between October 2019 and May 2021. The final acoustic dataset included 702 single recordings, corresponding to 351 couples of recordings from baseline and 12-months timepoints. Kappa coefficient was 0.57 (95% CI 0.55-0.58) for the presence of crackles and 0.42 (95% CI 0.41-0.43) for acoustic change. Intra-rater agreement, measured for three respiratory physicians on three repeated assessments, ranged from good to excellent for the presence of crackles (κ = 0.87, κ = 0.86, κ = 0.79), and from moderate to good for acoustic change (κ = 0.75, κ = 0.76, κ = 0.57).

Conclusions: Agreement between respiratory physicians for the presence of crackles and acoustic change was acceptable, suggesting that crackles represent a reliable acoustic finding in patients with fibrotic ILD. Their role as a lung-derived indicator of disease progression merits further studies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11439279PMC
http://dx.doi.org/10.1186/s12931-024-02979-9DOI Listing

Publication Analysis

Top Keywords

respiratory physicians
16
presence crackles
16
acoustic change
12
fibrotic interstitial
8
interstitial lung
8
lung disease
8
prospective longitudinal
8
crackles
8
agreement respiratory
8
physicians presence
8

Similar Publications

National survey on the presence of multidisciplinary meetings for interstitial lung diseases (ILD-MDM) in hospitals in Germany.

Z Rheumatol

September 2025

Clinic of Internal Medicine III, Department of Oncology, Hematology, Cell and Immunotherapies, Clinical Immunology and Rheumatology, University Hospital Bonn, Venusberg Campus 1, 53127, Bonn, Germany.

Background: Interstitial lung diseases (ILD) represent an interdisciplinary clinical challenge and are not uncommonly associated with rheumatological diseases. Interstitial lung disease multidisciplinary meetings (ILD-MDM) provide a structured platform for interdisciplinary case discussions and decision making. Despite their great importance in patient care, data on the prevalence, structure and function of ILD-MDM in Germany are lacking.

View Article and Find Full Text PDF

Introduction: Although peripheral venous blood gas (pVBG) analysis is used in the Emergency Department (ED), its effect on clinical decision making is unknown. We assessed whether pVBG analysis combined with pulse oximetry could replace arterial blood gas (ABG) analysis to determine treatment and disposition of ED patients with respiratory complaints. In addition, we assessed agreement between venous and arterial values and pulse oximetry (SpO2).

View Article and Find Full Text PDF

Fentanyl-blocking effects of extended-release naltrexone in humans: Three case reports.

J Opioid Manag

September 2025

Retired Addiction Physician and Psychiatrist, London SE1, United Kingdom. ORCID: https://orcid.org/0000-0002-5035-5833.

Despite the contribution of the µ-agonist fentanyl to the United States's opiate overdose epidemic, no human studies specifically address the ability of extended-release preparations of the opiate antagonist naltrexone (NTX) to block fentanyl's life-threatening µ-agonist-mediated respiratory depression. This paper presents three case histories of clinically necessary opiate challenges in opiate-abusing patients implanted with extended-release NTX (ER-NTX). It also reviews the sparse literature and is the first evidence that antagonist blood levels from ER-NTX preparations can completely block the lethal µ-agonist effects of at least 1,000 mcg of intravenous fentanyl.

View Article and Find Full Text PDF

Oxygen on Arrival: An Audit of Prescription Practices in the Emergency Assessment Unit.

Cureus

August 2025

Medicine, Salford Royal National Health Service (NHS) Foundation Trust, Manchester, GBR.

Introduction Oxygen is a routinely administered, yet prescription-only therapy in hospital settings. Inappropriate prescribing can result in significant harm, particularly in patients at risk of type 2 respiratory failure. This audit aimed to evaluate adherence to guidelines on oxygen prescribing during admission clerking in the Emergency Assessment Unit (EAU) of Salford Royal NHS Foundation Trust, a UK tertiary care hospital.

View Article and Find Full Text PDF

Objective:  Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder frequently associated with obesity, leading to increased risks of cardiovascular and renal complications. Dapagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, has emerged as a promising therapeutic agent for improving glycemic control and promoting weight reduction. However, evaluating its safety and efficacy in obese T2DM patients remains essential, particularly in real-world clinical settings.

View Article and Find Full Text PDF